Development of a competitive immunoassay for efavirenz: Hapten design and validation studies

Analytica Chimica Acta

Volumn 589, Issue 1, 2007, Pages 142-149

  Roucairol, Camille ^a   Azoulay, Stéphane ^a   Nevers, Marie Claire ^b   Créminon, Christophe ^b   Grassi, Jacques ^b   Burger, Alain ^a   Duval, Danièle ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b Institut National de la Recherche Agronomique   (France)

Author keywords

Efavirenz immunoassay; Hapten design; Human immunodeficiency virus; Therapeutic drug monitoring

Indexed keywords

DRUG THERAPY; ENZYMES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT MONITORING; PATIENT TREATMENT; PLASMA (HUMAN);

ENZYME IMMUNOASSAY (EIA); HAPTEN DESIGN; HUMAN IMMUNODEFIENCY VIRUS (HIV);

ANTIBIOTICS;

EFAVIRENZ; HAPTEN; POLYCLONAL ANTIBODY;

ACCURACY; ARTICLE; BODY FLUID; CLINICAL LABORATORY; ENZYME IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROTITER PLATE ASSAY; PATIENT MONITORING; PRIORITY JOURNAL; VALIDATION STUDY;

BENZOXAZINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HAPTENS; IMMUNOENZYME TECHNIQUES; REVERSE TRANSCRIPTASE INHIBITORS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 33947576589     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2007.02.045     Document Type: Article

References (21)

1. Adkins J.C., and Noble S. Drugs 56 (1998) 1055
2. Haas D.W., Ribaudo H.J., Kim R.B., Tierney C., Wilkinson G.R., Gulick R.M., Clifford D.B., Hulgan T., Marzolini C., and Acosta E.P. AIDS 18 (2004) 2391
3. Justesen U.S. Basic Clin. Pharmacol. Toxicol. 98 (2006) 20
4. Owen A., and Khoo S.H. J. HIV Ther. 9 (2004) 97
5. Marzolini C., Telenti A., Decosterd L.A., Greub G., Biollaz J., and Buclin T. AIDS 15 (2001) 71
6. Almond L.M., Hoggard P.G., Edirisinghe D., Khoo S.H., and Back D.J. J. Antimicrob. Chemother. 56 (2005) 738
7. Colombo S., Beguin A., Telenti A., Biollaz J., Buclin T., Rochat B., and Decosterd L.A. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 819 (2005) 259
8. Azoulay S., Nevers M.C., Creminon C., Heripret L., Durant J., Dellamonica P., Grassi J., Guedj R., and Duval D. Antimicrob. Agents Chemother. 48 (2004) 104
9. Tribut O., Verdier M.C., Arvieux C., Allain H., Michelet C., and Bentue-Ferrer D. Ther. Drug Monit. 27 (2005) 265
10. Mutlib A.E., Chen H., Nemeth G.A., Markwalder J.A., Seitz S.P., Gan L.S., and Christ D.D. Drug Metab Dispos. 27 (1999) 1319
11. Markwalder J.A., Christ D.D., Mutlib A., Cordova B.C., Klabe R.M., and Seitz S.P. Bioorg. Med. Chem. Lett. 11 (2001) 619
12. Pierce M.E., Parsons R.L., Radesca L.A., Lo Y.S., Silverman S., Moore J.R., Islam Q., Choudhury A., Fortunak J.M.D., Nguyen D., Luo C., Morgan S.J., Davis W.P., Confalone P.N., Chen C., Tillyer R.D., Frey L., Tan L., Xu F., Zhao D., Thompson A.S., Corley E.G., Grabowski E.J.J., Reamer R., and Reider P.J. J. Org. Chem. 63 (1998) 8536
13. Bates R.B., Kroposki L.M., and Potter D.E. J. Org. Chem. 37 (1972) 560
14. Mukaiyama T.K., Suzuki K.S., and Sato T. Chem. Lett. 5 (1979) 447
15. Huffman M.A., Nobuyoshi Y., DeCamp A.D., and Grabowski E.J.J. J. Org. Chem. 60 (1995) 1590
16. Corey E.J., and Cimprich K. J. Am. Chem. Soc. 116 (1994) 3151
17. Tan L., Chen C.Y., Tillyer R.D., Grabowski E.J.J., and Reider P.J. Angew. Chem. Int. Ed. 38 (1999) 711
18. J.T. Gregory, C. Falls, E. Jacob, US Patent No. 2,602,816 (1952).
19. Maurin M.B., Rowe S.M., Blom K., and Pierce M.E. Pharm. Res. 19 (2002) 517
20. Bland J.M., and Altman D.G. Lancet 1 (1986) 307
21. Pradelles P., Grassi J., and Maclouf J. Anal. Chem. 57 (1985) 1170